US Bancorp’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,950
| Closed | -$295K | – | 4236 |
|
|
2022
Q3 | $295K | Buy |
7,950
+7,332
| +1,186% | +$272K | ﹤0.01% | 1647 |
|
|
2022
Q2 | $12K | Sell |
618
-97
| -14% | -$1.88K | ﹤0.01% | 3298 |
|
|
2022
Q1 | $19K | Buy |
715
+164
| +30% | +$4.36K | ﹤0.01% | 3093 |
|
|
2021
Q4 | $12K | Buy |
551
+523
| +1,868% | +$11.4K | ﹤0.01% | 3337 |
|
|
2021
Q3 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 3964 |
|